Sign in
CompletedNo phase

Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis

Key facts

Who runs it
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Where
France2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
55 people enrolled
Started
6 Aug 2019
Ended
17 Jul 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Transorbital electrical stimulation (Eyetronic Next Wave 1.1)
  • Transorbital electrical stimulation (Eyetronic Next Wave 1.1) - Sham stimulation
Record updated
17 November 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (22)Hide the full registry criteria

Who can take part

  • For MS patients:
  • Age between 18 and 60 years old
  • Relapsing Remitting MS (criteria of McDonald 2017) evolving for less than 10 years or Clinically Isolated Syndrome (CIS)-MS with criteria of spatial dissemination on MRI
  • Subject presenting an acute unilateral episode of optic neuritis treated optimally (bolus of corticosteroids and plasma exchanges if considered necessary)
  • Last medical treatment for optic neuritis (NORB) received between 15 and 90 days before inclusion
  • Patient not fully recovered from the NORB episode (high- or low-contrast AV abnormality, persistent visual field deficit)
  • Subject affiliated with or covered by a social security scheme
  • Subject not affiliated with or a beneficiary of a social security scheme, unless an exemption granted by the Ethics Committee (CPP) following a request for derogation; For Healthy Volunteers:
  • Age between 18 and 60 years old
  • No history of neurological or ophthalmological diseases
  • Corrected visual acuity ≥ 8/10
  • affiliated with or beneficiary of a social security scheme

Who cannot take part

  • Impossibility to perform MRI, MEG, or electrical stimulation:; Pacemaker or neurosensory stimulator or implantable defibrillator Clip on an aneurysm or clip on a vascular malformation of the brain Cochlear implants Ocular or cerebral ferromagnetic foreign bodies Metal prostheses or metal clips or splinters Ventriculoperitoneal neurosurgical bypass valves Permanent makeup of the eyelids or lips Black tattoo, important and close to the cranio-facial sphere. Copper Intrauterine Device Person with proven claustrophobia Epilepsy Brain tumor Intraocular pressure without specific treatment Hypertension without treatment Acute retinal hemorrhage Periorbital skin irritation Significant cognitive deficit Known gadolinium allergy
  • Person with severe or uncontrolled symptoms of kidney, liver, hematological, gastrointestinal, pulmonary or cardiac disease or any uncontrolled intercurrent disease at the time of inclusion
  • Person with severe or uncontrolled symptoms of kidney, liver, hematological disease, gastrointestinal, pulmonary or cardiac disease or any uncontrolled intercurrent pathology at the time of inclusion
  • For patients:
  • Differential diagnosis of Optic neuritis:; Atypical acute optic neuritis (papillitis, severe papilledema, initial optic atrophy) ii) Optic neuromyelitis iii) Normal VEP during the inclusion visit iv) No detection of VEP during the inclusion visit
  • Pregnant or breath-feeding woman
  • person under judicial protection or deprived of liberty; For healthy volunteers:
  • Contraindication to MRI or MEG
  • Pregnant or breath-feeding woman
  • Person under the protection of justice or deprived of liberty

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In light of experimental models showing that neuronal electrical activity is crucial for the remyelination process, we hypothesize that maintenance of electrical axonal activity in the early stages of optic neuritis may promote myelin repair, limiting thereby axonal degeneration.

Read full original descriptionShow less

In humans, electrical stimulation of the optic nerve has been tested mainly in ischemic neuropathy and retinitis pigmentosa, which are both associated with severe axonal/retinal pathology and poor visual prognosis. In contrast, the inflammation of the optic nerve in optic neuritis is generally transient, with less severe axonal damage at the acute phase, which would allow for better efficacy of electrical stimulation as a strategy to promote remyelination and neuroprotection.In light of experimental models showing that neuronal electrical activity is crucial for the remyelination process, we hypothesize that maintenance of electrical axonal activity in the early stages of optic neuritis may promote myelin repair, limiting thereby axonal degeneration.

The 2 groups in the trial

  • Active Transorbital electrical stimulationTreatment being tested

    Transorbital electrical stimulation of the optic nerve - 10 sessions during 2 consecutive weeks

    Treatment: Transorbital electrical stimulation (Eyetronic Next Wave 1.1)

  • Sham Transorbital stimulationSham treatment, for comparison

    Sham stimulation - 10 sessions during 2 consecutive weeks

    Treatment: Transorbital electrical stimulation (Eyetronic Next Wave 1.1) - Sham stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 November 2026